Does Mounjaro Affect Periods — and What Should You Expect?

What clinical guidance actually says about tirzepatide and menstrual cycles

The NHS medicines page for tirzepatide lists common and uncommon side effects in detail. Menstrual irregularity does not appear among them. That is worth stating plainly, because the question comes up regularly and the honest starting point is that no direct causal mechanism between the drug molecule and cycle disruption has been established in trial data.

What the SURMOUNT-1 trial did show (published in the New England Journal of Medicine) is that tirzepatide produces substantial average weight loss over 72 weeks, around 20–21% of body weight at the 15mg dose in participants without diabetes. Losing that volume of body fat quickly is not hormonally neutral. This is where the evidence gets more relevant to periods.

Fat cells produce and store oestrogen. When adipose tissue decreases sharply, circulating oestrogen levels can shift in ways that disrupt the hypothalamic-pituitary-ovarian axis, the hormonal loop that controls the menstrual cycle. This is the same mechanism seen after bariatric surgery and in rapid dietary weight loss, and it is the most credible explanation when women on tirzepatide report cycle changes. You can read more about how tirzepatide works and what to expect during treatment.

The practical upshot: if you want a fuller picture of whether and how Mounjaro can affect your period, including what the evidence suggests about timing and severity, that page goes into more depth than we can cover here. That does not make it unimportant, it means tracking it matters.

The contraception fact that gets missed most often

There is one genuinely direct interaction between Mounjaro and reproductive health that is clearly documented in NHS England's guidance on weight-management injections: tirzepatide slows gastric emptying, and this can reduce how much of an oral contraceptive pill is absorbed into the bloodstream.

The clinical recommendation is specific. Women taking the pill should use an additional non-oral contraceptive method (condoms are the most practical choice) for the first four weeks of starting Mounjaro and for four weeks after every dose increase. This applies each time the dose steps up, not just at the beginning. The instruction exists because any unintended pregnancy while on tirzepatide would be a serious concern: the medicine is not recommended during pregnancy, and women are advised to use effective contraception throughout treatment.

If you use a contraceptive method that does not rely on oral absorption (an IUD, implant, injection, or patch) no additional precautions are required for this specific reason. If you are unsure which category your contraception falls into, that is a one-minute question worth putting to your prescriber before you start. It is also covered in the Mounjaro patient information leaflet, which is worth reading in full before your first injection.

HRT users are in a similar position: NHS England advises considering transdermal HRT (patches or gels) during tirzepatide treatment, for the same absorption reason. Discuss any current HRT with your prescriber at consultation.

What counts as a reason to contact your prescriber

Most cycle changes on Mounjaro will be mild and transient, settling as your weight stabilises or your body adjusts. A useful checking habit: keep a brief record in your phone's notes or a free period-tracking app for the first three months. A single line per cycle (start date, duration, any notable change) takes under a minute and gives your prescriber something concrete to work with if a review is needed.

Contact your GP or prescriber promptly if you experience: periods that stop entirely for three months or more, unusually heavy or prolonged bleeding, severe pelvic pain, or any symptoms that concern you independently of the medicine. These warrant investigation rather than watchful waiting. None of them are expected effects of Mounjaro, and other causes should be ruled out.

Fertility is a related topic worth raising directly. The licensing information does not suggest tirzepatide impairs fertility, but women planning a pregnancy should discuss timing with their prescriber; current guidance recommends stopping the medicine and allowing a wash-out period before trying to conceive. Our page on whether Mounjaro can affect your periods covers fertility questions in more depth, and our FAQs address some of the most common concerns from patients already on treatment.

How this affects your decision about starting treatment

For most women, the cycle changes associated with Mounjaro are a manageable side-note rather than a reason to avoid treatment altogether. The more relevant question is whether tirzepatide is clinically suitable for you, which depends on your BMI, health history, current medicines, and other factors only a prescriber can weigh up.

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or 27 and above with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. If you are also wondering whether Mounjaro can affect your periods specifically, that is something our GPhC-registered Independent Prescriber can address during the free consultation, where they review your answers the same day, not automated software. Questions about your contraception, cycle history, or HRT are all part of that conversation.

If you want background on what private treatment typically costs before you get started, the Mounjaro pricing page lays out what is and is not included in a transparent price. The weight-loss treatments overview is also a useful starting point if you are still comparing options.